Hidoc Dr | Medical Learning App for Doctors

Today's Updates

Ultragenyx Puts BLA for MPS IIIA Gene Therapy UX111 in Front of FDA Again Noah Stansfield

Published Date: 11 Feb 2026

Ultragenyx seeks FDA accelerated approval for UX111 gene therapy in Sanfilippo syndrome, citing neurologic benefit and the use of cerebral spinal fluid heparan sulfate data.

This Week on NeurologyLive® — February 9, 2026 Isabella Ciccone, MPH

Published Date: 11 Feb 2026

Here's some of what is coming soon to NeurologyLive® this week.

AGNOS Study Results Demonstrate Ofatumumab’s Impact on Neurofilament Light, GFAP Marco Meglio

Published Date: 11 Feb 2026

AGNOS trial showed that monthly treatment with ofatumumab lowered NfL and GFAP in patients with early RRMS, signaling reduced nerve damage and bolstering first-line treatment potential.

International Epilepsy Day 2026: Highlighting Gaps in Pediatric Care, Stigma, and Education Charuta Joshi, MD, Isabella Ciccone, MPH

Published Date: 11 Feb 2026

Pediatric neurologist Charuta Joshi, MD, discussed global disparities in epilepsy for children and adolescents amid International Epilepsy Day, highlighting opportunities for education, stigma reduction, and improved care access.

Regenxbio's MPS II Gene Therapy RGX-121 Hit With CRL Noah Stansfield

Published Date: 11 Feb 2026

The FDA issued a CRL for gene therapy RGX-121 in Hunter syndrome, citing trial design and biomarker doubts; Regenxbio seeks a meeting with the agency and resubmission.

Discussing Billing Challenges in Dermatology, With Daniel Siegel, MD Daniel M. Siegel, MD

Published Date: 11 Feb 2026

In this interview, Siegel highlights key points presented in his Maui Derm 2026 talk, 'How To Maximize Your Billing Effectiveness in the Era of Dwindling Reimbursements and ICD-10.'

New Phase 3 Findings Support Ameluz-PDT for Patients with Actinic Keratosis

Published Date: 11 Feb 2026

New Phase 3 Findings Support Ameluz-PDT for Patients with Actinic Keratosis

Knowledge Hub

Oncology

Giant Sebaceous Cyst of the Scalp Mimicking a Soft Tissue Tumor: A Case Study

A rare giant sebaceous cyst of the scalp presenting as a soft tissue tumor case study.

Oncology

Theranostics and Radioligand Therapy: Precision Cancer Care with Targeted Radionuclides

Precision cancer care using theranostics and radioligand therapy enhances targeted treatment and patient outcomes.

Oncology

Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization

Explore strategies for optimizing oncology trials, enhancing recruitment, decentralization, diversity, and patient-centered care.

Oncology

Optimizing Cancer Care: Multidisciplinary Approaches and Supportive Strategies

Enhance cancer care with multidisciplinary strategies, supportive therapies, and patient-centered interventions for better outcomes.

Oncology

KOL Videos

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug Database Drug Interaction Diseases Database

KOL Videos Knowledge Hub Quizzes

Medical Updates Events About Us

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation

Your one-stop Solution for MEDICAL LEARNING & UPDATES

Ultragenyx Puts BLA for MPS IIIA Gene Therapy UX111 in Front of FDA Again Noah Stansfield

This Week on NeurologyLive® — February 9, 2026 Isabella Ciccone, MPH

AGNOS Study Results Demonstrate Ofatumumab’s Impact on Neurofilament Light, GFAP Marco Meglio

International Epilepsy Day 2026: Highlighting Gaps in Pediatric Care, Stigma, and Education Charuta Joshi, MD, Isabella Ciccone, MPH

Regenxbio's MPS II Gene Therapy RGX-121 Hit With CRL Noah Stansfield

Discussing Billing Challenges in Dermatology, With Daniel Siegel, MD Daniel M. Siegel, MD

New Phase 3 Findings Support Ameluz-PDT for Patients with Actinic Keratosis

Knowledge Hub

Giant Sebaceous Cyst of the Scalp Mimicking a Soft Tissue Tumor: A Case Study

Theranostics and Radioligand Therapy: Precision Cancer Care with Targeted Radionuclides

Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization

Optimizing Cancer Care: Multidisciplinary Approaches and Supportive Strategies

The Future of Cancer Care: Genetics, Support Systems, and Emerging Therapies

Managing KRAS Inhibitor Toxicities: Focus on Rash and Beyond

Harnessing Artificial Intelligence in Oncology: Innovations in Diagnosis, Treatment, and Patient Care

KOL Videos

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

Quick Links

Page Views

Your one-stop Solution for MEDICAL LEARNING & UPDATES

Ultragenyx Puts BLA for MPS IIIA Gene Therapy UX111 in Front of FDA Again Noah Stansfield

This Week on NeurologyLive® — February 9, 2026 Isabella Ciccone, MPH

AGNOS Study Results Demonstrate Ofatumumab’s Impact on Neurofilament Light, GFAP Marco Meglio

International Epilepsy Day 2026: Highlighting Gaps in Pediatric Care, Stigma, and Education Charuta Joshi, MD, Isabella Ciccone, MPH

Regenxbio's MPS II Gene Therapy RGX-121 Hit With CRL Noah Stansfield

Discussing Billing Challenges in Dermatology, With Daniel Siegel, MD Daniel M. Siegel, MD

New Phase 3 Findings Support Ameluz-PDT for Patients with Actinic Keratosis

Knowledge Hub

Giant Sebaceous Cyst of the Scalp Mimicking a Soft Tissue Tumor: A Case Study

Theranostics and Radioligand Therapy: Precision Cancer Care with Targeted Radionuclides

Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization

Optimizing Cancer Care: Multidisciplinary Approaches and Supportive Strategies

The Future of Cancer Care: Genetics, Support Systems, and Emerging Therapies

Managing KRAS Inhibitor Toxicities: Focus on Rash and Beyond

Harnessing Artificial Intelligence in Oncology: Innovations in Diagnosis, Treatment, and Patient Care

KOL Videos

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

Quick Links

Verification

Welcome to Hidoc Dr.

Page Views